Author

Luis Enrique Flores-Padilla

Institutions: Mexican Social Security Institute, Universidad Autónoma de Zacatecas "Francisco García Salinas"

Observed institutions: Mexican Social Security Institute, Universidad Autónoma de Zacatecas "Francisco García Salinas", Instituto Politécnico Nacional

ORCID: 0009-0006-4827-8281

Observed ORCID: 0009-0006-4827-8281

OpenAlex ID: A5113300768

The Repurposing of FDA-Approved Drugs as FtsZ Inhibitors against Mycobacterium tuberculosis: An In Silico and In Vitro Study

2024 · Andrea Michel Tovar-Nieto, Luis Enrique Flores-Padilla, et al. · Microorganisms · 14

Therapeutic targeting of Respiratory Syncytial Virus: Current pharmacological options and future directions in antiviral development

2026 · Luisa Fernanda Ontiveros-Zúñiga, Sharon Itzel Sosa-Mondragon, et al. · Microbiological Research · 4

Virology-aware artificial intelligence for respiratory antiviral discovery: from molecular docking biases to RdRp-centered benchmarking

2026 · Luis Ruben Ramos-Cortes, Alan Orlando Santos-Mena, et al. · Frontiers in Pharmacology

Works count: 3

Citation count: 18

H-index: 2

I10-index: 1